Digital Biomarkers· 2017Q2
Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home
- 3,186citations
- Q2SCImago
- 2017year
Short summary
Wearable sensors successfully captured objective activity data in individuals with Parkinson's and Huntington's disease, demonstrating feasibility and identifying significant differences in lying-down time compared to controls.
AI-generated from the title and abstract; the full text is not read.
Key points
- 99.3% of wearable sensors dispatched successfully obtained data.
- Huntington's disease patients spent over 50% of time lying down, significantly more than other groups.
- 86% of participants were willing to wear the sensors again.
- Sensors identified statistically significant differences in activity profiles between patient groups and controls.
AI-generated from the title and abstract; the full text is not read.
Abstract
<b><i>Background:</i></b> Clinician rating scales and patient-reported outcomes are the principal means of assessing motor symptoms in Parkinson disease and Huntington disease. However, these assessments are subjective and generally limited to episodic in-person visits. Wearable sensors can objectively and continuously measure motor features and could be valuable in clinical research and care. <b><i>Methods:</i></b> We recruited participants with Parkinson disease, Huntington disease, and prodromal Huntington disease (individuals who carry the genetic marker but do not yet exhibit symptoms of the disease), and controls to wear 5 accelerometer-based sensors on their chest and limbs for standardized in-clinic assessments and for 2 days at home. The study’s aims were to assess the feasibility of use of wearable sensors, to determine the activity (lying, sitting, standing, walking) of participants, and to survey participants on their experience. <b><i>Results:</i></b> Fifty-six individuals (16 with Parkinson disease, 15 with Huntington disease, 5 with prodromal Huntington disease, and 20 controls) were enrolled in the study. Data were successfully obtained from 99.3% (278/280) of sensors dispatched. On average, individuals with Huntington disease spent over 50% of the total time lying down, substantially more than individuals with prodromal Huntington disease (33%, <i>p</i> = 0.003), Parkinson disease (38%, <i>p</i> = 0.01), and controls (34%; <i>p</i> &#x3c; 0.001). Most (86%) participants were “willing” or “very willing” to wear the sensors again. <b><i>Conclusions:</i></b> Among individuals with movement disorders, the use of wearable sensors in clinic and at home was feasible and well-received. These sensors can identify statistically significant differences in activity profiles between individuals with movement disorders and those without. In addition, continuous, objective monitoring can reveal disease characteristics not observed in clinic.
The authors' abstract, as published at the source. Digital Biomarkers, 2017 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Cellular and Molecular Neuroscience
Cellular and Molecular NeuroscienceNeuroscience